Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

24
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Insulin resistance and type 2 diabetes as allostatic responses to chronic nutrient excess.

Cell metabolism·2026
Same author

Lipidomic profiling reveals a distinct lipidomic signature of early gestational diabetes.

Communications medicine·2026
Same author

A longitudinal study of partner support and maternal mental health following pregnancy during public health crises.

Journal of affective disorders·2026
Same author

Development and validation of the gestational diabetes mellitus holistic healthcare needs scale.

Primary care diabetes·2026
Same author

Ketone Profiles in Community-Dwelling Adults with Type 1 Diabetes Using Continuous Ketone Monitoring.

Diabetes technology & therapeutics·2026
Same author

Objective perimetry and diabetic retinopathy progression: a 10-year follow-up study.

Frontiers in endocrinology·2026

Related Experiment Video

Updated: May 1, 2026

A Model of Chronic Nutrient Infusion in the Rat
08:18

A Model of Chronic Nutrient Infusion in the Rat

Published on: August 14, 2013

12.2K

Lipotoxicity, β cell dysfunction, and gestational diabetes.

Christopher J Nolan1

  • 1Department of Endocrinology at Canberra Hospital and the Australian National University Medical School, Canberra, Australian Capital Territory 2605, Australia.

Cell Metabolism
|April 8, 2014
PubMed
Summary

Gestational diabetes (GDM) is linked to a specific metabolite, 3-carboxy-4-methyl-5-propyl-2-furanopropanoic acid (CMPF). This compound, found at higher levels in GDM patients, directly impairs insulin-producing beta cell function.

More Related Videos

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

70.1K
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

12.6K

Related Experiment Videos

Last Updated: May 1, 2026

A Model of Chronic Nutrient Infusion in the Rat
08:18

A Model of Chronic Nutrient Infusion in the Rat

Published on: August 14, 2013

12.2K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

70.1K
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

12.6K

Area of Science:

  • Endocrinology
  • Metabolomics
  • Reproductive Medicine

Background:

  • Gestational diabetes mellitus (GDM) arises when pancreatic islet beta cells cannot meet the heightened insulin demands during pregnancy.
  • Pregnancy-induced metabolic changes can lead to beta cell stress and dysfunction, contributing to GDM development.

Purpose of the Study:

  • To investigate the role of specific plasma metabolites in the pathophysiology of gestational diabetes mellitus.
  • To identify potential biomarkers associated with GDM and beta cell dysfunction.

Main Methods:

  • Analysis of plasma samples from women with and without GDM.
  • Quantification of furan fatty acid metabolites, specifically 3-carboxy-4-methyl-5-propyl-2-furanopropanoic acid (CMPF).
  • In vitro assessment of CMPF's direct effects on beta cell function.

Main Results:

  • A significant 7-fold elevation of CMPF was observed in the plasma of women diagnosed with GDM compared to controls.
  • Experimental data demonstrated that CMPF directly induces dysfunction in pancreatic islet beta cells.

Conclusions:

  • Elevated levels of the furan fatty acid metabolite CMPF are strongly associated with gestational diabetes.
  • CMPF is identified as a direct causative agent of beta cell dysfunction in the context of GDM, highlighting its pathogenic role.